PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
67.77
-0.98 (-1.43%)
At close: Apr 2, 2026, 4:00 PM EDT
67.37
-0.40 (-0.59%)
After-hours: Apr 2, 2026, 6:11 PM EDT
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$1,746,372
Profits / Employee
$688,844
Market Cap
5.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Rhythm Pharmaceuticals | 414 |
| Mirum Pharmaceuticals | 372 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
PTCT News
- 10 days ago - PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors - PRNewsWire
- 22 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 24 days ago - PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 5 weeks ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - PTC Therapeutics: Sephience As A Major Growth Driver - Seeking Alpha
- 6 weeks ago - PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire